Although established as an effective drug target in AML, previous data has shown that FLT3 is downregulated in response to hypoxic stress,43 indicating that other signalling pathways influence the ability of AML cells to escape cell death and to proliferate in hypoxic environments. The gene discussed is FLT3; the disease is acute myeloid leukemia.